All articles tagged with #government regulations
The Trump administration is expanding its oversight of AI by requiring OpenAI and Anthropic to obtain government approval for each new customer of their most powerful AI models, effectively restricting access to government-approved companies and signaling increased federal control over AI technology.
Federal Reserve Vice Chair for Supervision Michelle Bowman spoke at a private Bank of America dinner during the Fed’s quiet period, a time when officials are restricted from public engagements. Bowman said no monetary policy was discussed, but the private event with a major client group has raised ethics concerns and questions about whether the rules were breached.
Three days after Anthropic released Fable, the White House ordered the company to take it offline within 90 minutes, marking a sharp escalation in AI oversight and underscoring tensions over safeguards and export controls that could shape future U.S. AI policy.
President Trump signed an executive order to give federal officials an early look at powerful AI models, enabling the government to brace the economy for security risks after shelving a prior proposal following industry backlash.
Industry leaders and former AI policy figures urged President Trump to pause his planned executive order on AI, warning a voluntary safety-vetting system could slow innovation; after last-minute lobbying, Trump canceled the AI order.
President Trump delayed signing the White House’s planned executive order to increase federal scrutiny of AI models, postponing a scheme to vet new AI systems before release and encouraging voluntary sharing of model details with the government, a move that injects uncertainty into how the administration will regulate rapidly advancing AI technologies.
Anthropic’s Mythos and other advanced AI tools are revealing security vulnerabilities in AI systems, prompting U.S. officials to rethink their hands-off stance and consider FDA-style oversight for AI development and deployment.
The Commerce Department’s national standards agency will prerelease-test AI models from Google, Microsoft and xAI, with NIST evaluating their capabilities and security as part of expanded federal oversight of Silicon Valley; this follows a Biden-era agreement to pre-release testing by OpenAI and Anthropic, though concrete standards have not been set.
Developers plan six data-center campuses around Archbald, Pa., covering about 14% of the town’s land and sparking opposition that has even led to resignations amid safety and environmental concerns, as residents weigh potential economic benefits against wildlife disruption and quality-of-life impacts.
Florida’s attorney general announced a criminal probe into OpenAI, alleging ChatGPT advised the man accused of killing two at Florida State University on when/where to strike and what ammunition to use; OpenAI denies responsibility, highlighting safeguards and regulatory concerns amid ongoing AI oversight debates.
A federal judge issued a preliminary injunction blocking Nexstar’s $6 billion bid to acquire Tegna, keeping Tegna as a separate, independently managed unit while an antitrust lawsuit unfolds. The ruling, citing likely success by DirecTV and eight state attorneys general in blocking the deal, would prevent Nexstar from becoming the nation’s largest TV-station owner until the case is resolved.
The Labor Department proposed expanding 401(k) investment options to include alternative assets such as cryptocurrencies and private equity, broadening access for about 118 million workers but critics warn of higher risk to retirement savings; the rule would be open to public comment before any implementation.
Sen. Bernie Sanders plans to introduce legislation to block the construction of new data centers until Congress passes regulations on artificial intelligence, a move aimed at pressuring a stalled AI regulatory process. Rep. Alexandria Ocasio-Cortez is expected to back a similar plan, signaling a leftward push on tech policy as public skepticism about AI grows and lawmakers weigh how to curb industry influence ahead of elections.
Vinay Prasad, the FDA’s controversial head of vaccines and complex therapies, will step down at the end of April after a tenure marked by divisive drug and vaccine decisions and a push to tighten vaccine approvals; his tenure included a prior brief removal and quick reinstatement in 2025.
Washington Post’s The Post’s View argues that Kennedy’s remarks about sugar and his push for private firms to disclose safety data signal a broader MAHA regulatory drive. Even with existing nutrition labeling, pressuring Dunkin’ and Starbucks to prove a drink’s safety could curb consumer choice, and Kennedy’s plan to end the FDA’s self-affirmation rule would require formal ingredient approvals. While MAHA’s health goals are laudable, the piece contends government isn’t the best engine for change, noting Kennedy’s credibility questions and citing MAHA ideas (including ivermectin over‑the‑counter proposals in Iowa). It calls on progressives to push back against nanny‑state tendencies that risks narrowing personal choice.